A tale of two patients with Mendelian hypertension

Hypertension

Volumn 51, Issue 3, 2008, Pages 609-614

  Quack, Ivo ^a   Vonend, Oliver ^b   Sellin, Lorenz ^a   Stegbauer, Johannes ^a   Dekomien, Gabriele ^b,c   Rump, Lars Christian ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

18 HYDROXYHYDROCORTISONE; ALDOSTERONE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BISOPROLOL; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; EPLERENONE; HYDROCHLOROTHIAZIDE; NIFEDIPINE; POTASSIUM; RENIN; SODIUM; URAPIDIL;

ADENOMA; ADRENAL DISEASE; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD GAS ANALYSIS; BLOOD PRESSURE MEASUREMENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; METABOLIC ALKALOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALDOSTERONE SYNTHASE; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MALE; MUTATION; STEROID 11-BETA-HYDROXYLASE;

EID: 39749182207     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.101915     Document Type: Article

References (41)

1. Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3-17.
2. Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med. 1967;66:1079-1090.
3. Kaplan NM. Is there an unrecognized epidemic of primary aldosteronism? Con. Hypertension. 2007;50:454-458, discussion:454-458.
4. Woywodt A, Herrmann A, Choi M, Goebel U, Luft FC. Turkish pepper (extra hot). Postgrad Med J. 2000;76:426-428.
5. Stowasser M, Gordon RD. Monogenic mineralocorticoid hypertension. Best Pract Res Clin Endocrinol Metab. 2006;20:401-420.
6. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res. 2007;30:111-117.
7. Hartman D, Sagnella GA, Chesters CA, Macgregor GA. Direct renin assay and plasma renin activity assay compared. Clin Chem. 2004;50:2159-2161.
8. Vonend O, Altenhenne C, Buchner NJ, Dekomien G, Maser-Gluth C, Weiner SM, Sellin L, Hofebauer S, Epplen JT, Rump LC. A German family with glucocorticoid-remediable aldosteronism. Nephrol Dial Transplant. 2007;22:1123-1130.
9. Daunt N Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics. 2005;25 Suppl 1:S143-158.
10. Diederich S, Mai K, Bahr V, Helffrich S, Pfeiffer A, Perschel FH. The simultaneous measurement of plasma-aldosterone- and -renin-concentration allows rapid classification of all disorders of the renin-aldosterone system. Exp Clin Endocrinol Diabetes. 2007;115:433-438.
11. Keberle E, Brenneis H, Haag M, Keberle M. [Reninoma: a rare cause of hypertension. Case report, review of the literature and possibility for organ preserving operation]. Urologe A. 2000;39:352-355.
12. McVicar M, Carman C, Chandra M, Abbi RJ, Teichberg S, Kahn E. Hypertension secondary to renin-secreting juxtaglomerular cell tumor: case report and review of 38 cases. Pediatr Nephrol. 1993;7:404-412.
13. Luft FC. Mendelian forms of human hypertension and mechanisms of disease. Clin Med Res. 2003;1:291-300.
14. Frey FJ, Ferrari P. Pastis and hypertension-what is the molecular basis? Nephrol Dial Transplant. 2000;15:1512-1514.
15. Young WF Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology. 2003;144:2208-2213.
16. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
17. Miyahara K, Kawamoto T, Mitsuuchi Y, Toda K, Imura H, Gordon RD, Shizuta Y. The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity. Biochem Biophys Res Commun. 1992;189:885-891.
18. Stowasser M, Bachmann AW, Huggard PR, Rossetti TR, Gordon RD. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. J Clin Endocrinol Metab. 2000;85:2160-2166.
19. Stowasser M, Gordon RD, Tunny TJ, Klemm SA, Finn WL, Krek AL. Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism. Clin Exp Pharmacol Physiol. 1992;19:319-322.
20. So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI, Stowasser M. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens. 2005;23:1477-1484.
21. Abdelhamid S, Blomer R, Hommel G, Haack D, Lewicka S, Fiegel P, Krumme B. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. Am J Hypertens. 2003;16:522-530.
22. Seiler L, Rump LC, Schulte-Monting J, Slawik M, Borm K, Pavenstadt H, Beuschlein F, Reincke M. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol. 2004;150:329-337.
23. Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, Maser-Gluth C, Mechelhoff D, Tauber R, Diederich S. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem. 2004;50:1650-1655.
24. Gordon RD. Primary aldosteronism-actual epidemics or false alarm? Ar Qbras Endocrinol Metabol. 2004;48:666-673.
25. Vonend O, Rump LC. [Normokalemic primary hyperaldosteronism]. Dtsch Med Wochenschr. 2006;131:H24-27.
26. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40:897-902.
27. Vonend O, Stegbauer J, Kokulinsky P, Adams S, Liermann D, Hahn K, Rump LC. [Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism]. Dtsch Med Wochenschr. 2007; 132:2436-2441.
28. Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW, Vidt DG. The changing clinical spectrum of primary aldosteronism. Am J Med. 1983;74:641-651.
29. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina AC, Mantero F. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens. 2007;25:1433-1442.
30. Ganguly A, Dowdy AJ, Luetscher JA, Melada GA. Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab. 1973;36:401-404.
31. Young WF Jr. Pheochromocytoma and primary aldosteronism: diagnostic approaches. Endocrinol Metab Clin North Am. 1997;26:801-827.
32. Lingam RK, Sohaib SA, Rockall AG, Isidori AM, Chew S, Monson JP, Grossman A, Besser GM, Reznek RH. Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome). Eur Radiol. 2004;14:1787-1792.
33. Patel SM, Lingam RK, Beaconsfield TI, Tran TL, Brown B. Role of radiology in the management of primary aldosteronism. Radiographics. 2007;27:1145-1157.
34. Pascoe L, Jeunemaitre X, Lebrethon MC, Curnow KM, Gomez-Sanchez CE, Gasc JM, Saez JM, Corvol P. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest. 1995;96:2236-2246.
35. Hirono Y, Doi M, Yoshimoto T, Kanno K, Himeno Y, Taki K, Sasano H, Hirata Y. A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules. Endocr J. 2005;52:435-439.
36. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:1227-1235.
37. Mattsson C, Young WF Jr. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol. 2006;2:198-208; quiz, 191 p following 230.
38. Rossi GP. New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Curr Hypertens Rep. 2007;9:90-97.
39. Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003;21:2149-2157.
40. Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon RD. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun. 1995;207:565-571.
41. Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab. 1998;83:2573-2575.